Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015
- 25 April 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 143 (2) , 251-260
Abstract
Purpose Germ cell tumors (GCT) in the central nervous system (CNS) are rare tumors that occur with highest frequency in males, Asian populations, and children less than age 20 years. Due to the rarity of these tumors, their patterns of incidence are not well-described. The aim of this study is to provide the most up-to-date data on incidence and survival patterns for CNS GCT by sex, race, and age at diagnosis. Methods The Central Brain Tumor Registry of the United States (CBTRUS) is the largest aggregation of population-based incidence data on primary brain and other CNS tumors in the United States, containing incidence data from 51 central cancer registries and representing 100% of the US population. The current study used the CBTRUS analytic file to examine incidence (IR) of CNS GCT from 2006 to 2015, as well as registry data from the Surveillance, Epidemiology, and End Results (SEER) program to examine survival. Results Males had greater IR than females in all CNS GCT histologies examined. Asian and Pacific Islanders had a significantly greater IR of CNS GCT than the other race categories. We confirmed that CNS GCT IR was greatest for those age 10–14 years and male. Overall survival rates were high for malignant CNS GCT, germinoma, mixed GCT, and malignant teratoma. Conclusions There is significant variation in CNS GCT incidence by sex, race, and age at diagnosis. Ascertaining accurate incidence and survival rates of CNS GCT provides vital information usable in real time for clinicians, public health planners, patients, and their families.Keywords
Funding Information
- Centers for Disease Control and Prevention (2016-M-9030)
- American Brain Tumor Association
- Sontag Foundation
- Novocure
- AbbVie
- Musella Foundation For Brain Tumor Research and Information
- Division of Cancer Epidemiology and Genetics (HHSN261201800176P)
- Zelda Dorin Tetenbaum Memorial Fund
- Cancer Prevention and Research Institute of Texas (RP160097T)
This publication has 15 references indexed in Scilit:
- Surgical management of primary central nervous system germ cell tumorsJournal of neurosurgery. Pediatrics, 2010
- Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiationPediatric Blood & Cancer, 2010
- Primary chemotherapy for intracranial germ cell tumors: Results of the third international CNS germ cell tumor studyPediatric Blood & Cancer, 2010
- Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysisNeuro-Oncology, 2009
- Incidence Patterns of Central Nervous System Germ Cell TumorsJournal of Pediatric Hematology/Oncology, 2009
- The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumorsPediatric Blood & Cancer, 2008
- Pediatric Central Nervous System Germ Cell Tumors: A ReviewThe Oncologist, 2008
- Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell TumorsJournal of Clinical Oncology, 2004
- Primary Chemotherapy for Intracranial Nongerminomatous Germ Cell Tumors: Results of the Second International CNS Germ Cell Study Group ProtocolJournal of Clinical Oncology, 2004
- Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor StudyNeuro-Oncology, 2001